Pre- and Post- COVID-19 Exposure Prophylaxis: Ep1 - Introduction

IMPACT Medicom

In this podcast series on pre- and post- COVID-19 prophylaxis, we discuss immunization against COVID-19 and how we can protect our most vulnerable populations who are not able to mount a sufficient antibody response to vaccination.
In this first episode of the series, we discuss:

• Response to COVID-19 vaccines in the general population
• Populations who have a reduced response to vaccination
• The difference between active and passive immunization
• The potential role of pre- and post- COVID-19 exposure prophylaxis for vulnerable populations

Our Guest:

Our guest is Dr. Brian Conway, who is an infectious diseases specialist and the medical director of the Vancouver Infectious Diseases Centre, dedicated to the development and evaluation of systems of care for inner city vulnerable population. The models his team has established have led to increased access to HIV and HCV care as well as addiction services in a unique and durable manner. He is an adjunct professor in the Faculty of Health Sciences at Simon Fraser University. In 2012, he received the Queen Elizabeth II Diamond Jubilee Medal for long-standing service to the country in the field of HIV. In 2020, the Coalition for Global Hepatitis Elimination recognized Dr. Conway’s group as one of 6 global elimination champions. In the times of COVID-19, he has been sought out by local and national media to help Canadians make sense of the pandemic. Through generous funding from the Public Health Agency of Canada, he is currently involved in optimizing vaccine and treatment understanding and uptake among inner city residents.
This podcast episode was sponsored by AstraZeneca Canada.

If you enjoy our podcast, please review and subscribe. For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com